Sudden
increase in infertility cases have compelled foreign companies to eye Asian
countries for expansion
Increasing trends towards a delayed pregnancy
has rapidly grown in countries like China. Research Analysts at Allied Market
Research tracking the major growth, share and size and trends in the
Asia-Pacific IVF devices and consumables market say the commercialization of
affordable fertility treatments and notable rise in the medical tourism in the
region has offered lucrative opportunities. Apart from this, the proactive
measures to build a novel technology are expected to facilitate its dynamic
development in Asia – Pacific region. The infertility cases over the past few
years have increased owing to different factors. These factors consist of
rising disposable income, advent of new tourism destinations, and environmental
pollution among others.
Asia-Pacific IVF Devices and Consumables
Market Welcomes International Companies
Several international companies are planning on entering the Asia
–Pacific market. They are set to launch their business with heavy investment
initially. Many have plans to take over IVF firms as well as wide range of
other firms that are now operating in a fragmented sector. In a recent
development Medicover a Sweden based company has entered India and hired Gaurav
Malhotra who has earlier worked with Bourn Hall. Felipe Velasquez, the commercial director at the company said "The company is
looking at having 50 green-field Medicover Fertility clinics in three years.” He
further explained “Of the 50 clinics, the company will open four—two in Delhi
and one each in Noida and Gurgaon—in two months and aims to have 10 clinics by
the end of the year.”
Certain Policies Pushes Asia-Pacific IVF
Devices and Consumables Market to Next Level
An end to policies such as one – child policy in China has opened has opened new opportunities for the IVF sector in the
country. Demand for in vitro fertilization in China is likely to increase after
Beijing decided to scrap its much debated one –child policy last October. This
has already started straining the overcrowded hospitals run the state but has
opened new avenues for many overseas health facilities to train the local
doctors and underground centers. In addition, many doctors at the IVF clinics
reveal that they are now capable enough to do gender selection without much
documentation. Apart from this, recent statistics show that there has been
around 50 percent rise in consultations since the government body in China has
decided to end the one-child policy.
Women
Rely on Asia-Pacific IVF Devices
and Consumables Market More Than Over
There has been a record rise in the number of women using in vitro
fertilization to get pregnant. The increasing trend however does not mean that
Asians are having more trouble in conceiving children. It may indicate that several couples are deciding to kids later. Women
in Asian countries such as India are having much later in their life span that
they did few years back. Moreover, women today are lot healthier than were ages
ago owing to factors including changing lifestyle and environment pollution are
declining.
Eyeing the major development in the industry, Allied Market Research has
published a research report titled “Asia-Pacific IVF Devices and ConsumablesMarket - Opportunities and Forecasts, 2014 – 2020.” The study is aimed at
examining the important business factors such as growth rate, share and size
and trends keeping the prospects of the industry high. Researchers apply both
primary and secondary study techniques to explore the sector by instrument,
technology, technology, end –users and geography. The research covers some of
the key market players such as OvaScience, Inc., Vitrolife AB, Thermo Fisher Scientific, Inc., Cooper Surgical, Inc., Genea Biomedx as well as
Irvine Scientific among many others.
